|
Aug 8
|
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
|
|
Aug 4
|
Orion Corporation: Managers’ transactions – Satu Ahomäki
|
|
Jul 23
|
Peptic Ulcer Drugs Market Forecast Report 2025-2034 | FDA Approves New Helicobacter pylori Treatment; Market Growth Expected
|
|
Jul 21
|
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
|
|
Jul 18
|
Orion Group Half-Year Financial Report January–June 2025
|
|
Jul 18
|
Orion Corporation’s financial reporting and Annual General Meeting in 2026
|
|
Jun 23
|
141,959 Orion Corporation A shares converted into B shares
|